Leprosy Drug Supply Restored in Nigeria After Year-Long Shortage

 In a significant development, people affected by leprosy in Nigeria will finally have access to essential medication for the first time in over a year, according to the World Health Organization (WHO). The country sees more than 2,000 new leprosy cases annually, but a lack of supplies, exacerbated by new regulations, has left many without necessary treatments.The WHO has confirmed that it requested Nigeria to temporarily lift its stringent testing policies, paving the way for vital drugs to arrive from India this coming Sunday. While leprosy is effectively treatable with a combination of antibiotics, failure to receive medication can lead to severe health issues, including debilitating sores and irreversible nerve damage.Dr. Samimu Msheliza, a public health expert at the Nigerian branch of the Leprosy Mission, emphasized the urgent need for this medication, noting that countless newly diagnosed patients across various urban centers have been awaiting treatment. "The more swiftly we obtain these drugs, the better. Currently, these individuals are suffering, and without treatment, the transmission of the disease continues," Dr. Msheliza warned.Speaking to Reuters, Awwal Musa, a patient at a hospital in Nasarawa state, expressed the dire impact of the lack of medication on her health. "My fingers have become clawed, and my legs discharge pus. Before last year, my wounds were healing, but now they are worsening and more painful," she reported.The regulatory changes that contributed to the drug shortages aimed to combat the importation of counterfeit and substandard medications. While these measures were well-intentioned, they inadvertently hindered access to critical treatments for leprosy, leaving many patients in prolonged suffering. As the situation unfolds, the return of leprosy drugs to Nigeria holds the promise of renewed hope for thousands battling this ancient disease.